Dr Lalchandani Labs Valuation

Q: What is the Fair Price of 541299 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

541299 (₹18) is trading below our estimate of [[fair value]] (₹440.9)

Is 541299 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 541299 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 541299 (₹18) is trading below our estimate of fair value (₹440.9)

Significantly Below Fair Value: 541299 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 541299?

Key metric: As 541299 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 541299. This is calculated by dividing 541299's market cap by their current earnings.
What is 541299's PE Ratio?
PE Ratio	9.1x
Earnings	₹8.58m
Market Cap	₹78.00m

541299 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	2x
Enterprise Value/EBITDA	20.6x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does 541299's PE Ratio compare to its peers?

The above table shows the PE ratio for 541299 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	18.5x
544220 Clinitech Laboratory	34.4x	n/a	₹180.3m
542918 Gian Life Care	4.9x	n/a	₹196.6m
526301 Medinova Diagnostic Services	21x	n/a	₹403.9m
531043 Dhanvantri Jeevan Rekha	13.6x	n/a	₹81.1m
541299 Dr Lalchandani Labs	9.1x	n/a	₹78.0m

Price-To-Earnings vs Peers: 541299 is good value based on its Price-To-Earnings Ratio (9.1x) compared to the peer average (18.5x).

Price to Earnings Ratio vs Industry

How does 541299's PE Ratio compare vs other companies in the IN Healthcare Industry?

2 Companies	Price / Earnings	Estimated Growth	Market Cap
523696 Fortis Malar Hospitals	2.1x	n/a	US$11.76m
542918 Gian Life Care	4.9x	n/a	US$2.33m

No more companies available in this PE range

2 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: 541299 is good value based on its Price-To-Earnings Ratio (9.1x) compared to the Indian Healthcare industry average (41.9x).

Price to Earnings Ratio vs Fair Ratio

What is 541299's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

541299 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	9.1x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 541299's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Medico Intercontinental

₹592.5m

Trades in pharmaceutical products.

539938

₹59.25

28.6%

-37.0%

N G Industries

₹547.0m

Provides various healthcare services in India.

530897

₹163.25

-2.7%

-2.5%

Adeshwar Meditex

₹340.0m

Manufactures and exports sterile wound dressings, first aid kits, pharmaceuticals, and other medical disposables in India and internationally.

543309

₹23.56

-5.8%